Journal: International Journal of Pharmaceutics: X
Article Title: Hyaluronic acid microneedle patch for transdermal delivery of naringin-loaded PEGylated terpesomes in a rat model of rheumatoid arthritis: Modulation TGF-β1, oxidative stress, and inflammation
doi: 10.1016/j.ijpx.2026.100527
Figure Lengend Snippet: Effects of different treatments on inflammatory biomarkers measured by ELISA: (a) mTOR, (b) IL-1β, (c) Lipid peroxidation (LPO, ex-pressed as MDA levels), (d) MMP3, (e) TNF-α, (f) NF-KB, (g) IL-6,qPCR expression gene 88 (MYD88)(h), thioredoxin interacting protein (TXNIP)(i), and B-cell lymphoma 2 (BCL-2)(j). Data are expressed as mean ± SD ( n = 10). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, and ns (not significant) versus the control group. Abbreviations: GI (healthy negative control), GII (RA model, untreated), GIII (treated with Naringin gel containing 2% w/w HPMC), GIV (treated with Naringin-loaded terpesomes in gel with 2% w/w HPMC), and GV (treated with Naringin-loaded terpesomes incorporated in Hyaluronic acid microneedles).
Article Snippet: Hydroxypropyl methylcellulose (HPMC; K4M) was supplied by Dow Chemical Company in Midland, MI.
Techniques: Enzyme-linked Immunosorbent Assay, Expressing, Control, Negative Control